Michelle Pernice reports a stock award at MTRI
By AlphaYouPublished Form 4
Pernice Michelle Patricia
Reporting filer
Michelle Patricia Pernice reports a stock award, not an open-market purchase or sale, in InMed Pharmaceuticals Inc.. Form 4 filed Nov 12, 2026 lists 1 entry.
- Disclosed
- Nov 12, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) (derivative) | Pernice Michelle Patricia | 2026-11-09 | A | Grant or award | 37000 | 0 | 37,000 | 3 days | Filed terms
|
Stock Option (Right to Buy) (derivative)
- Owner
- Pernice Michelle Patricia
- Date
- 2026-11-09
- Code
- A
- Action
- Grant or award
- Quantity
- 37000
- Price
- 0
- Following holdings
- 37,000
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 16.00
- transaction Date: 2026-11-09
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 37000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-11-09
- underlying Security Title: Common Stock
- underlying Security Shares: 37000
- shares Owned Following Transaction: 37000
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Pernice Michelle Patricia: Director.
- F1: This option represents the right to purchase 37,000 shares of the Issuer's common stock and will vest in equal monthly installments through November 9, 2029, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
Original sources
Prepared automatically from public filing data. Report a correction.